Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.
about
Sublingual immunotherapy for asthmaHow does the efficacy and safety of Oralair(®) compare to other products on the market?Sublingual Immunotherapy: A Useful Tool for the Allergist in Private PracticeChoosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dosePlant-based vaccines for animals and humans: recent advances in technology and clinical trialsCurrent status of sublingual immunotherapy in the United StatesDevelopment and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patientsAllergic conjunctivitis in Asia.Sublingual immunotherapy: World Allergy Organization position paper 2013 update.A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitisOral and sublingual immunotherapy.Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined scoreThe efficacy assessment of a self-administered immunotherapy protocolPharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis.New directions in immunotherapy.Emerging therapies in allergic conjunctivitis and dry eye syndrome.Investigational drugs for the treatment of allergic rhinitis.A comparative analysis of symptom and medication scoring methods used in clinical trials of sublingual immunotherapy for seasonal allergic rhinitis.Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience.Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.A milestone in house dust-mite-allergen immunotherapy: the new sublingual tablet S-524101 (actair).Updating the role played by immunotherapy for allergic rhinitis: meta-analysis.Immunotherapy in all aspects.Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany.Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review.Adverse Events During Immunotherapy Against Grass Pollen-Induced Allergic Rhinitis - Differences Between Subcutaneous and Sublingual Treatment.Current developments for improving efficacy of allergy vaccines.Pharmacodynamic and pharmacokinetic evaluation of house dust mite sublingually administered immunotherapy tablet in the treatment of asthma.Allergen extracts for immunotherapy: to mix or not to mix?Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North America.Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles.Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.Immunotherapy in allergic rhinitis and lower airway outcomes.Proteomics for Allergy: from Proteins to the Patients.Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient.Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.MK-8237: a house dust mite vaccine for treating allergic rhinitis, asthma and atopic dermatitis.Comparison of six disease severity scores for allergic rhinitis against pollen counts a prospective analysis at population and individual level.Debates in Allergy Medicine: Allergy skin testing cannot be replaced by molecular diagnosis in the near future.
P2860
Q24187736-B0016BE4-6445-4BB8-BB1B-CC5193E4C05FQ26745596-6A942D42-1FBE-4355-8237-322D0DC1F091Q26747200-32A8B793-5E2F-4852-AE76-1FC84A795A62Q26772069-08981572-054E-4A09-8C3F-A50D7C3656D3Q26775788-50DD879C-080C-4D65-A75C-483636B58CB6Q27025077-2D0FF008-49B7-49EF-9740-53ADF5971BA2Q27700098-A67947DF-CE7B-48C0-94B4-91F4E06429DAQ30234510-3B0703CD-A58D-4069-AFB3-CDEB3CCC2784Q30440195-603194E9-D894-44D6-8ED3-6A8F1887B961Q33914193-BEE6C6B2-D89E-4D16-8B4B-59997D33EC98Q34044108-B9CDF3D3-5FC3-4F17-8E95-F260C13BEE8CQ35761230-979492B6-766D-44E2-8B45-C235B4D76A4DQ36881918-53551E43-AB49-4D03-9DEB-115FE1958EBCQ37684339-F51BC621-6146-4899-BD3C-DF767CEC1C05Q38073718-27EB3228-5FA5-43BB-AF76-3EA0CC1D6B10Q38119024-39BF2EC6-F824-4841-948E-917ED76560A5Q38202695-8A8F8F03-A762-465D-A6F2-EB1352D88AFEQ38207691-FCC03E4F-A921-4C56-A4E9-E274038573C4Q38247821-5B582F15-B132-4DFC-ABFC-6E6AFEDDD661Q38262168-4B381096-086E-493F-A0DE-2817018C29A7Q38262772-8B04579B-DC84-4FD0-ACF2-89E811FF98EDQ38271427-8C12222B-C40C-49D8-996C-9EDA2C2E7937Q38352179-A2B37ECA-93D0-40AC-A54A-FD384116DD77Q38359800-5D7C9326-03FF-41A1-938D-833D1BCE8ADCQ38366788-9464C30A-15E1-46AD-94EE-808D200A6B9BQ38476590-A502A9FB-59F9-4742-9DA2-B36F6B3E76EEQ38503330-DF917FEE-8254-4D26-A7CD-214B8D87BBD7Q38632661-660551F1-FC9A-4857-BECB-E0E91B8E30BDQ38664847-B272CD08-7DAD-42BE-A819-C478CF032449Q38712422-94B56A9F-CFEC-48DF-9C8C-E1A9F7E4753CQ38745619-C30C7DE9-E6BB-424F-948F-074B5F33459BQ38792200-83607B07-915F-460C-BF2F-58AAD1E19A32Q38888019-2BC059E8-5BD6-49D7-85A5-106C5CDA567BQ38903486-CE72EADB-A6AA-45BB-9B7C-F84F732D2FBBQ38930142-4B641602-89DA-4FB3-9814-465DEDFA6AC8Q38968310-4249EF7B-98CF-45B9-B9FF-11434FDEBEB8Q39115606-ADB75763-BADF-440E-B6BB-EFF667BCE188Q39399204-27E2786A-C8DF-487E-9796-B958C2908A36Q39908406-2131DC7D-B3FB-45A4-87CE-78382559BC3DQ42360646-15C9B760-3913-4A11-A19D-90D6F653FB38
P2860
Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinical efficacy of 300IR 5-g ...... f allergen-specific serum IgE.
@en
Clinical efficacy of 300IR 5-g ...... f allergen-specific serum IgE.
@nl
type
label
Clinical efficacy of 300IR 5-g ...... f allergen-specific serum IgE.
@en
Clinical efficacy of 300IR 5-g ...... f allergen-specific serum IgE.
@nl
prefLabel
Clinical efficacy of 300IR 5-g ...... f allergen-specific serum IgE.
@en
Clinical efficacy of 300IR 5-g ...... f allergen-specific serum IgE.
@nl
P2093
P1476
Clinical efficacy of 300IR 5-g ...... f allergen-specific serum IgE.
@en
P2093
Anjuli S Nayak
David I Bernstein
Laurence Ambroisine
Linda S Cox
Michel Melac
Peter S Creticos
Robert K Zeldin
Thomas B Casale
P304
1327-34.e1
P356
10.1016/J.JACI.2012.08.032
P407
P577
2012-10-31T00:00:00Z